Atlas Trials

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets

Clinical trial NCT03740217 · COMPLETED

Trial details

NCT number
NCT03740217
Sponsor
Calliditas Therapeutics AB
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Phase 1
Start date
2018-12-19
Primary completion
2019-02-06
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.